How the liver regulates blood sugar

The liver as the body's glucose reservoir

The liver sits at a crossroads of the body's fuel supply, and among its many roles it is the organ most responsible for keeping a steady amount of glucose in the bloodstream between meals. It does this by acting as both a storehouse and a small factory: it can lock glucose away when there is plenty in circulation, and it can give that glucose back — or manufacture more from scratch — when the supply runs low.

Because it can move in both directions, the liver is often described as a buffer or reservoir for blood glucose. Blood returning from the intestines passes through the liver first, by way of the portal vein, so the liver gets an early read on how much glucose is arriving from a meal and can respond before that glucose reaches the rest of the body. This positioning is part of why the liver, rather than any single other organ, is understood to do so much of the moment-to-moment regulation.

The liver does not decide this on its own; it takes its cues largely from two pancreatic hormones, insulin and glucagon, which pull in opposite directions. This article is educational only and is not medical advice; it describes how the liver's handling of glucose is understood to work, not what any individual should do.

Banking glucose as glycogen

After a carbohydrate-containing meal, glucose flows into the bloodstream and, through the portal vein, into the liver. In this well-fed state, insulin is the dominant signal, and the liver is understood to respond by stringing individual glucose molecules together into glycogen — a large, branched storage form of glucose. This building process is called glycogenesis, and it lets the liver take some of the incoming sugar out of circulation and hold it in a compact, readily retrievable form.

Glycogen functions as the liver's short-term savings account for glucose. It can be assembled quickly when glucose is abundant and taken apart quickly when it is needed, which makes it well suited to smoothing out the hours around meals. The liver is not the only tissue that stores glycogen — skeletal muscle holds a large share too — but, as the next section describes, the liver is comparatively unusual in being able to release that stored glucose back into the general bloodstream rather than keeping it for itself.

Releasing stored glucose: glycogenolysis

Between meals and overnight, blood glucose begins to drift downward, glucagon becomes the dominant signal, and the liver reverses course. It breaks its stored glycogen back down into individual glucose units, a process called glycogenolysis. The enzyme glycogen phosphorylase is understood to carry out much of this work, clipping glucose molecules from the ends of the branched glycogen chains so they can be freed for release.

One detail explains why the liver, specifically, can top up blood sugar this way. Glucose freed from glycogen initially carries a phosphate group that traps it inside the cell. The liver possesses an enzyme called glucose-6-phosphatase that removes this group, converting the molecule into free glucose that can cross out of the cell and into the blood. Muscle, which stores plenty of glycogen, largely lacks this enzyme, so it tends to burn its glycogen for its own energy rather than share it. This is a central reason the liver — along with the kidney — is understood to be the main organ that returns glucose to circulation.

The liver's glycogen stores are finite, however, and during a longer stretch without food they are gradually drawn down. When that reserve begins to run low, the liver leans on a second, more involved mechanism to keep glucose flowing.

Making new glucose: gluconeogenesis

Gluconeogenesis — literally the making of new glucose — is the liver's ability to manufacture glucose from non-carbohydrate raw materials. It becomes the more important source of glucose during prolonged fasting, once glycogen is largely spent. Rather than releasing sugar it had banked earlier, the liver assembles brand-new glucose molecules step by step.

The raw materials are gathered from around the body. Lactate produced by hard-working muscle and by red blood cells is carried to the liver and rebuilt into glucose, a recycling route known as the Cori cycle. Certain amino acids released as protein is broken down — alanine is a prominent example — can be converted into glucose as well. Glycerol, the backbone left over when stored fat is broken apart, is a third source. From these building blocks the liver runs a series of enzymatic steps, involving enzymes such as PEPCK and, again, glucose-6-phosphatase at the final step, to produce free glucose it can release.

Because gluconeogenesis and glycogenolysis both feed glucose into the blood, they are together described as the liver's glucose output, or hepatic glucose production. This upstream supply is what keeps glucose-dependent tissues — the brain in particular — supplied through the night and during fasting. It is also the step that several metabolic medications are studied in relation to, as the next section notes.

The insulin-glucagon balance the liver reads

The liver's choice between storing glucose and supplying it is governed less by either hormone alone than by the balance between them. When insulin is high relative to glucagon — the fed state — the balance tips toward storage: the liver favors glycogenesis and its glucose output is suppressed. When glucagon is high relative to insulin — the fasting state — the balance tips toward supply: glycogenolysis and gluconeogenesis are favored, and the liver releases and makes more glucose. Because the liver responds to this shifting ratio continuously, it can move smoothly between banking and dispensing glucose as the body's state changes.

This is why the liver's glucose output is of such interest in the study of metabolic health. When the liver is understood to release more glucose than the body needs — for example, in the context of insulin resistance — that excess output is one contributor researchers point to. Some prescription medications are studied specifically for how they act on this hepatic step. Metformin, available in an extended-release form (metformin-xr) as one neutral example of the category, is understood to act in part by reducing the amount of glucose the liver produces; the detailed cellular mechanism is its own subject. Whether such a medication is appropriate for a given person is a clinical judgment, not something an article can determine.

Describing these mechanisms is not a diagnosis, an assessment, or a recommendation for any individual. It is background on how a single organ is understood to help keep blood glucose within a narrow range.

How it works on OpenDoseRx

On OpenDoseRx, a licensed clinician — not the shopper — makes the medical decision. You choose a product and strength, then complete a medical intake with your health history. An independent, licensed U.S. provider reviews that intake and decides whether a prescription is appropriate for you.

If it is, a licensed U.S. pharmacy prepares and ships it; if the provider declines, you are not charged for the medication and receive a full refund. This article is educational only and is not a substitute for a conversation with your own healthcare provider.